Skip to main content

Articles

Page 54 of 335

  1. To investigate the differences in HPV genotypes and clinical indicators between cervical squamous cell carcinoma and adenocarcinoma and to identify independent predictors for differentiating cervical squamous ...

    Authors: Zhimin He, Rongsheng Chen, Shangying Hu, Yajiao Zhang, Yang Liu, Chengwei Li, Fajin Lv and Zhibo Xiao
    Citation: BMC Cancer 2022 22:776
  2. Many previous studies have demonstrated that minor-frequency pretreatment T790M mutation (preT790M) could be detected by ultrasensitive methods in a considerable number of treatment-naïve, epidermal growth fac...

    Authors: Yoshiya Matsumoto, Tomoya Kawaguchi, Masaru Watanabe, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Chiyoe Kitagawa, Naoki Yoshimoto and Yasuhiro Koh
    Citation: BMC Cancer 2022 22:775
  3. Abbreviated breast MRI (A-MRI) substantially reduces the image acquisition and reading times and has been reported to have similar diagnostic accuracy as a full diagnostic protocol but has not been evaluated p...

    Authors: Marina Mohallem Fonseca, Tasneem Alhassan, Yashmin Nisha, Diana Koszycki, Betty Anne Schwarz, Roanne Segal, Angel Arnaout, Tim Ramsay, Jacqueline Lau and Jean M. Seely
    Citation: BMC Cancer 2022 22:774

    The Correction to this article has been published in BMC Cancer 2022 22:1009

  4. Cancer is a frightening disease. Therefore, the care of cancer patients is very complex. This study aimed to investigate the effect of the education based on Orem’s self-care model on self-care abilities of th...

    Authors: Tayebeh Rakhshani, Siamak Najafi, Fakhry Javady, Alireza Taghian dasht bozorg, Fatemeh Mohammadkhah and Ali Khani Jeihooni
    Citation: BMC Cancer 2022 22:770
  5. Breast cancer is the most common cancer among women in Brazil and the country’s public health care system is the main care provider. Timely treatment can increase the chance of cure, prevent metastasis and imp...

    Authors: Ranailla Lima Bandeira dos Santos, Vera Lúcia Edais Pepe and Claudia Garcia Serpa Osorio-de-Castro
    Citation: BMC Cancer 2022 22:769
  6. This study aimed to determine the pathological complete response (pCR), overall survival (OS), and disease-free survival (DFS) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) using ...

    Authors: Wei-Hsiang Feng, Ying-Yi Chen, Yen‐Shou Kuo, Kuan-Hsun Lin, Yuan-Ming Tsai, Ti-Hui Wu, Hsu-Kai Huang and Tsai-Wang Huang
    Citation: BMC Cancer 2022 22:768
  7. Immune checkpoint inhibitors (ICI) treatment in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) offers new therapeutic venues. We have previously developed a predictive survival model ...

    Authors: Majd Issa, Brett G. Klamer, Nikol Mladkova, Georgios I. Laliotis, Vidhya Karivedu, Priyanka Bhateja, Chase Byington, Khaled Dibs, Xueliang Pan, Arnab Chakravarti, John Grecula, Sachin R. Jhawar, Darrion Mitchell, Sujith Baliga, Matthew Old, Ricardo L. Carrau…
    Citation: BMC Cancer 2022 22:767
  8. Drug resistance is a considerable challenge for chemotherapy in non-small cell lung cancer (NSCLC). Propofol, a commonly used intravenous anesthetics, has been reported to suppress the malignancy of various ca...

    Authors: Quan Ling, Shaoyong Wu, Xiaozu Liao, Chiyi Liu and Yong Chen
    Citation: BMC Cancer 2022 22:765
  9. The tumor microenvironment is a dynamic cellular milieu that interacts with cancer cells and promotes tumor progression and metastasis. However, the specific mechanisms by which the tumor microenvironment impa...

    Authors: Hao Feng, Boxiong Cao, Xuan Peng and Qiang Wei
    Citation: BMC Cancer 2022 22:764
  10. The impact of pectoralis muscle mass index (PMI) on cardiac events is not well studied in cancer patients, especially in those who have received chemotherapy with high potential cardiac toxicity such as anthra...

    Authors: Wael Toama, Jason Wiederin, Ryan Shanley, Patricia Jewett, Christina Gu, Chetan Shenoy, Prabhjot S. Nijjar and Anne H. Blaes
    Citation: BMC Cancer 2022 22:763
  11. Clinical staging of gastric cancer (GC) before treatment is essential. Endoscopic ultrasound (EUS) is a recommended staging tool, but its efficacy remains controversial. Our previous prospective study evaluate...

    Authors: Yan Yan, Zhonghua Ma, Xin Ji, Jiawei Liu, Ke Ji, Shijie Li and Qi Wu
    Citation: BMC Cancer 2022 22:761
  12. Breast cancer (BCa) is the leading cause of cancer deaths among women. Reliable biomarkers for early diagnosis and metastasis prediction are essential to improve the prognosis of BCa. This study aimed to evalu...

    Authors: Li Jia, Guanhua Li, Na Ma, Aimin Zhang, Yunli Zhou, Li Ren and Dong Dong
    Citation: BMC Cancer 2022 22:760
  13. Circulating cell free DNA (cfDNA) testing of plasma for EGFR somatic variants in lung cancer patients is being widely implemented and with any new service, external quality assessment (EQA) is required to ensure ...

    Authors: Jennifer A. Fairley, Melanie H. Cheetham, Simon J. Patton, Etienne Rouleau, Marc Denis, Elisabeth M. C. Dequeker, Ed Schuuring, Kaat van Casteren, Francesca Fenizia, Nicola Normanno and Zandra C. Deans
    Citation: BMC Cancer 2022 22:759
  14. Although chondrosarcoma is the second most common primary malignant bone tumor, treatment options are limited due to its extensive resistance to a chemo- and radiation therapy. Since shikonin has shown potent ...

    Authors: Birgit Lohberger, Dietmar Glänzer, Heike Kaltenegger, Nicole Eck, Andreas Leithner, Rudolf Bauer, Nadine Kretschmer and Bibiane Steinecker-Frohnwieser
    Citation: BMC Cancer 2022 22:758
  15. Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid and easily develops into distant metastasis. PD-L1 is known to be associated with the carcinogenesis and progression of thyroi...

    Authors: Jianguang Lin, Yanru Qiu, Xueqin Zheng, Yijun Dai and Tianwen Xu
    Citation: BMC Cancer 2022 22:756
  16. Innovative therapies have improved the overall survival in melanoma, although a high number of patients still experience disease progression or recurrence. Ex-vivo culture of circulating tumour cells (CTCs) re...

    Authors: Claudia Felici, Francesco Mannavola, Luigia Stefania Stucci, Loren Duda, Paola Cafforio, Camillo Porta and Marco Tucci
    Citation: BMC Cancer 2022 22:754
  17. Progestin is used for fertility-sparing treatment in cases of endometrial cancer (EC). Progestin can induce hyperprolactinemia by increasing pituitary secretion and endometrial decidualization. However, proges...

    Authors: Wenjing Gu, Akira Mitsuhashi, Tatsuya Kobayashi and Makio Shozu
    Citation: BMC Cancer 2022 22:753
  18. Tyrosine kinase inhibitors (TKIs) are mainstays of cancer treatment. However, their clinical benefits are often constrained by acquired resistance. To overcome such outcomes, we have rationally engineered APG-...

    Authors: Douglas D. Fang, Ran Tao, Guangfeng Wang, Yuanbao Li, Kaixiang Zhang, Chunhua Xu, Guoqin Zhai, Qixin Wang, Jingwen Wang, Chunyang Tang, Ping Min, Dengkun Xiong, Jianyong Chen, Shaomeng Wang, Dajun Yang and Yifan Zhai
    Citation: BMC Cancer 2022 22:752
  19. To describe and analyze the predictive models of the prognosis of patients with hepatocellular carcinoma (HCC) undergoing systemic treatment.

    Authors: Li Li, Xiaomi Li, Wendong Li, Xiaoyan Ding, Yongchao Zhang, Jinglong Chen and Wei Li
    Citation: BMC Cancer 2022 22:750
  20. Midostaurin combined with chemotherapy is currently used to treat newly diagnosed acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3 (FLT3)-mutations. However, midostaurin acts as an antagon...

    Authors: Hao Lu, Xiang-qin Weng, Yan Sheng, Jing Wu, Hui-min Xi and Xun Cai
    Citation: BMC Cancer 2022 22:749
  21. Cancer-associated fibroblasts (CAFs) play an important role in cancer growth by interacting with cancer cells, but their effects differ depending on the type of cancer. This study investigated the role of CAFs...

    Authors: Ryota Tanaka, Kenjiro Kimura, Shimpei Eguchi, Go Ohira, Shogo Tanaka, Ryosuke Amano, Hiroaki Tanaka, Masakazu Yashiro, Masaichi Ohira and Shoji Kubo
    Citation: BMC Cancer 2022 22:748
  22. The residual effects of cancer and its treatment can profoundly affect women’s quality of life. This paper presents results from a multisite randomized controlled trial that evaluated the clinical benefits of ...

    Authors: Charrlotte Seib, Debra Anderson, Amanda McGuire, Janine Porter-Steele, Nicole McDonald, Sarah Balaam, Diksha Sapkota and Alexandra L. McCarthy
    Citation: BMC Cancer 2022 22:747
  23. Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy.

    Authors: Edward Yu, Alison L. Allan, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Lori E. Lowes, David A. Palma, Jacques Raphael, Mark D. Vincent, George B. Rodrigues, Dalilah Fortin, Richard I. Inculet, Eric Frechette, Joel Bierer…
    Citation: BMC Cancer 2022 22:746
  24. The role of the PRDM5 in esophageal squamous cell carcinoma (ESCC) has not been revealed. This study investigated the relationship between PRDM5 expression and survival outcome in esophageal squamous cell carc...

    Authors: Jing Guo, Qiuxing Yang, Sheng Wei, Jingjing Shao, Tianye Zhao, Liyuan Guo, Jia Liu, Jia Chen and Gaoren Wang
    Citation: BMC Cancer 2022 22:745
  25. Cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN) (K3)—a novel synthetic single-stranded DNA immune adjuvant for cancer immunotherapy—induces a potential Th1-type immune response against cancer cells. ...

    Authors: Tomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara, Burcu Temizoz, Masanari Hamaguchi, Takayuki Shiroyama, Keiko Kimura, Kotaro Miyake, Haruhiko Hirata, Yumiko Mizuno, Mayu Yagita, Yusuke Manabe, Etsushi Kuroda, Yoshito Takeda, Hiroshi Kida, Ken J. Ishii…
    Citation: BMC Cancer 2022 22:744
  26. In most previous studies, single-incision laparoscopic surgery (SILS) for colorectal cancer (CRC) was feasible and safe in the short term. However, long-term oncologic outcomes remain uncertain, as only a few ...

    Authors: Zijia Song, Kun Liu, Tao Zhang, Bingshun Wang, Yiqing Shi, Yimei Jiang, Changgang Wang, Xianze Chen, Xiaopin Ji and Ren Zhao
    Citation: BMC Cancer 2022 22:743
  27. The use of oxaliplatin in digestive tract cancers could induce severe peripheral neuropathy (OIPN) decreasing the quality of life of patients and survivors. There is currently, no univocal treatment for these ...

    Authors: Nicolas Kerckhove, David Tougeron, Côme Lepage, Denis Pezet, Karine Le Malicot, Manon Pelkowski, Bruno Pereira and David Balayssac
    Citation: BMC Cancer 2022 22:742
  28. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) reduces neutropenia events and is widely used in cancer patients receiving chemotherapy. However, the effects of rhG-CSF on distant organ metas...

    Authors: Yong Wang, Chen Fang, Renfang Chen, Shangkun Yuan, Lin Chen, Xiaotong Qiu, Xiaoying Qian, Xinwei Zhang, Zhehao Xiao, Qian Wang, Biqi Fu, Xiaoling Song and Yong Li
    Citation: BMC Cancer 2022 22:741
  29. Papillary and follicular thyroid carcinomas can be treated surgically and with radioiodine therapy, whereas therapeutic options for advanced stage IV medullary and for anaplastic tumours are limited. Recently,...

    Authors: Max Czajkowski, Daniel Kaemmerer, Jörg Sänger, Guido Sauter, Ralph M. Wirtz, Stefan Schulz and Amelie Lupp
    Citation: BMC Cancer 2022 22:740
  30. The present study aimed to explore the application value of random survival forest (RSF) model and Cox model in predicting the progression-free survival (PFS) among patients with locoregionally advanced nasoph...

    Authors: Wei Pei, Chen Wang, Hai Liao, Xiaobo Chen, Yunyun Wei, Xia Huang, Xueli Liang, Huayan Bao, Danke Su and Guanqiao Jin
    Citation: BMC Cancer 2022 22:739
  31. Immune checkpoint blockade (ICB) only works well for a certain subset of patients with non-small cell lung cancer (NSCLC). Therefore, biomarkers for patient stratification are desired, which can suggest the mo...

    Authors: Jie Mei, Guanyu Jiang, Yundi Chen, Yongrui Xu, Yuan Wan, Ruo Chen, Feng Liu, Wenjun Mao, Mingfeng Zheng and Junying Xu
    Citation: BMC Cancer 2022 22:738
  32. Immune checkpoint inhibitors (ICIs) have been used to successfully treat primary liver cancer (PLC); however, identifying modifiable patient factors associated with therapeutic benefits is challenging. Obesity...

    Authors: Lu-shan Xiao, Rui-ning Li, Hao Cui, Chang Hong, Chao-yi Huang, Qi-mei Li, Cheng-yi Hu, Zhong-yi Dong, Hong-bo Zhu and Li Liu
    Citation: BMC Cancer 2022 22:737
  33. For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the lab...

    Authors: Kelly Dufraing, Kaat Van Casteren, Joke Breyne, Nicky D’Haene, Claude Van Campenhout, Sara Vander Borght, Karen Zwaenepoel, Etienne Rouleau, Ed Schuuring, Jan von der Thüsen and Elisabeth Dequeker
    Citation: BMC Cancer 2022 22:736
  34. The therapeutic armamentarium in multiple myeloma has been significantly broadened by proteasome inhibitors, highly efficient means in controlling of multiple myeloma. Despite the developments of therapeutic r...

    Authors: Azam Salimi, Kema Marlen Schroeder, Mirle Schemionek-Reinders, Margherita Vieri, Saskia Maletzke, Deniz Gezer, Behzad Kharabi Masouleh and Iris Appelmann
    Citation: BMC Cancer 2022 22:735
  35. This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12885-021-08923-0

    Authors: Wenpeng Zhao, Jiang Guo, Honglu Li, Liang Cai, Youjia Duan, Xiaopu Hou, Zhenying Diao, Xihong Shao, Hongliu Du and Changqing Li
    Citation: BMC Cancer 2022 22:733
  36. The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of ...

    Authors: Mariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, Virginia Calvo, Enric Carcereny, Alexandra Cantero, Reyes Bernabé, Gretel Benitez, Rafael López Castro, Bartomeu Massutí, Edel del Barco, Rosario García Campelo, Maria Guirado, Carlos Camps, Ana Laura Ortega, Jose Luis González Larriba…
    Citation: BMC Cancer 2022 22:732
  37. An uninterrupted dose of oxaliplatin-based cytotoxic therapy is an essential component in the standard treatment regimen of metastatic colon cancer (mCC). Data on the impacts of dose intensity reduction on the...

    Authors: Mohd Naqib Zainal Abidin, Marhanis Salihah Omar, Farida Islahudin and Noraida Mohamed Shah
    Citation: BMC Cancer 2022 22:731
  38. Symptom Screening in Pediatrics Tool (SSPedi) was developed for symptom screening by children 8-18 years. Objectives were to evaluate the reliability and validity of proxy-SSPedi and self-report mini-SSPedi fo...

    Authors: Deborah Tomlinson, L. Lee Dupuis, Donna L. Johnston, Susan Kuczynski, Serina Patel, Tal Schechter, Emily Vettese, Mark Mairs, George A. Tomlinson and Lillian Sung
    Citation: BMC Cancer 2022 22:730
  39. Glioblastoma is one of the most common brain cancers in adults, and is characterized by recurrence and little curative effect. An effective treatment for glioblastoma patients remains elusive worldwide. 7-meth...

    Authors: Xinrui Wu, Chuanyu Li, Zhisu Wang, Yundi Zhang, Shifan Liu, Siqi Chen, Shuai Chen, Wangrui Liu and Xiaoman Liu
    Citation: BMC Cancer 2022 22:729
  40. Osteosarcoma (OS) is the most common primary malignant bone tumors in children and adolescents. Large numbers of studies have focused on the long non-coding RNA (lncRNA) that plays essential roles in the progr...

    Authors: Zhen Wang, Yanting Wei, Hao Zhu, Lingfeng Yu, Jie Zhu, Qixiu Han, Ziying Liu, Jianhao Huang, Yan Zhu, Gentao Fan, Qikai Tang, Ji Qian, Xi Chen and Guangxin Zhou
    Citation: BMC Cancer 2022 22:728
  41. The PD-L1 antibody is an immune checkpoint inhibitor (ICI) attracting attention. The third-generation anticancer drug has been proven to be very effective due to fewer side effects and higher tumor-specific re...

    Authors: Guen Tae Kim, Eun Young Kim, Su-Hyun Shin, Hyowon Lee, Se Hee Lee, Ki-Young Sohn and Jae Wha Kim
    Citation: BMC Cancer 2022 22:727
  42. Metastatic soft tissue sarcoma (STS) are a heterogeneous group of malignancies which are not curable with chemotherapy alone. Therefore, understanding the molecular mechanisms of sarcomagenesis and therapy res...

    Authors: Vasileia Tsintari, Bianca Walter, Falko Fend, Mathis Overkamp, Christian Rothermundt, Charles D. Lopez, Marcus M. Schittenhelm and Kerstin M. Kampa-Schittenhelm
    Citation: BMC Cancer 2022 22:725

Featured videos

View featured videos from across the BMC-series journals